Theo-24
Drug - Theo-24
The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Theophylline
Multiple ingredients are in alphabetical order.
Strength -
200MG
The potency of the active ingredient(s), Theophylline. May repeat for multiple part products.
Applicant -
UCB
The firm name holding legal responsibility for Theo-24. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
087943
The FDA assigned number to Theo-24. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Theo-24. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
BC
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Aug 22, 1983
The date Theo-24 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Theo-24. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Theo-24 is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Ucb Pharma Inc
The full name of the firm holding legal responsibility for the new application of Theo-24.
Theo-24
Slo-phyllin 60mg Capsule, Extended Release; Oral Somophyllin-crt 100mg Capsule, Extended Release; Oral Somophyllin-crt 200mg Capsule, Extended Release; Oral Somophyllin-crt 250mg Capsule, Extended Release; Oral Somophyllin-crt 300mg Capsule, Extended Release; Oral Somophyllin-crt 50mg Capsule, Extended Release; Oral Theo-24 100mg Capsule, Extended Release; Oral Theo-24 200mg Capsule, Extended Release; Oral Slo-phyllin 125mg Capsule, Extended Release; Oral Slo-phyllin 250mg Capsule, Extended Release; Oral
NewDrugInformation
|